Eftrenonacog Alfa | m-entrepreneurship.com

Product Name :
Eftrenonacog Alfa

Search keywords :
G-1

drugId :
null

Target Vo:
Coagulation factor X

Target Vo Short Name :
F10

Moa_Name:
Coagulation factor X stimulants

First Approval Country :
United States

First Approval Date Filter:
2014

Origin Company_Name :
Sobi

Active Company_Name :
Biogen Idec Medical Consulting (Shanghai) Co Ltd

Active Indication_Name:
Hemophilia B

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Modotuximab Epigenetics
Recaticimab Protocol
pVHL Antibody: pVHL Antibody is a non-conjugated and Mouse origined monoclonal antibody about 24 kDa, targeting to pVHL. It can be used for IHC-P assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts